| RS1057519143 |
SNRNP200
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057519145 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519146 |
CYP2U1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519148 |
TNC
|
Health Risk |
Likely pathogenic |
— |
| RS1057519149 |
KMT2A
|
Health Risk |
Likely pathogenic |
— |
| RS1057519150 |
TECTA
|
Health Risk |
Likely pathogenic |
Hearing impairment, Hearing impairment |
| RS1057519152 |
MEGF10
|
Health Risk |
Likely pathogenic |
— |
| RS1057519155 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS1057519157 |
SYNE1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519160 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1057519162 |
CRB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy, Optic atrophy |
| RS1057519164 |
KIF1A
|
Health Risk |
Pathogenic |
— |
| RS1057519165 |
CEP290
|
Health Risk |
Pathogenic |
Nephronophthisis, Joubert syndrome |
| RS1057519166 |
GARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1057519167 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1057519168 |
ACVRL1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519169 |
ERBB3
|
Health Risk |
Likely pathogenic |
— |
| RS1057519172 |
ERLIN2
|
Health Risk |
Pathogenic |
— |
| RS1057519173 |
RYR1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519174 |
COL6A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Bethlem myopathy 1A, COL6A1-related disorder |
| RS1057519179 |
DMD
|
Health Risk |
Conflicting classifications of pathogenicity |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1057519180 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS1057519181 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Inborn genetic diseases |
| RS1057519182 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1057519183 |
VPS13B
|
Health Risk |
Conflicting classifications of pathogenicity |
Cohen syndrome, Cohen syndrome |
| RS1057519188 |
FIG4
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS1057519189 |
STXBP1
|
Health Risk |
Pathogenic |
Epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS1057519190 |
SCN8A
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 13 |
| RS1057519191 |
COL4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1057519193 |
USH2A
|
Health Risk |
Pathogenic |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1057519195 |
KIF5A
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 10, Hereditary spastic paraplegia 10 |
| RS1057519197 |
CACNA1A
|
Health Risk |
Likely pathogenic |
— |
| RS1057519200 |
RPGRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy 13, Leber congenital amaurosis 6 |
| RS1057519201 |
GABRB3
|
Health Risk |
Conflicting classifications of pathogenicity |
Epilepsy, childhood absence |
| RS1057519205 |
RIMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ornithine aminotransferase deficiency, Ornithine aminotransferase deficiency |
| RS1057519208 |
USH2A
|
Health Risk |
Likely pathogenic |
— |
| RS1057519210 |
SCN8A
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1057519212 |
HSD17B4
|
Health Risk |
Likely pathogenic |
— |
| RS1057519213 |
SETX
|
Health Risk |
Likely pathogenic |
— |
| RS1057519216 |
MECP2
|
Health Risk |
Likely pathogenic |
— |
| RS1057519220 |
TH
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive DOPA responsive dystonia, Autosomal recessive DOPA responsive dystonia |
| RS1057519221 |
MYH7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS1057519223 |
NKX2-1
|
Health Risk |
Likely pathogenic |
Brain-lung-thyroid syndrome, Brain-lung-thyroid syndrome |
| RS1057519225 |
MYO7A
|
Health Risk |
Pathogenic/Likely pathogenic |
Usher syndrome type 2, Usher syndrome type 2 |
| RS1057519228 |
CHD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy 94, Developmental and epileptic encephalopathy 94 |
| RS1057519229 |
NPC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type C1 |
| RS1057519232 |
COG7
|
Health Risk |
Likely pathogenic |
— |
| RS1057519234 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1057519236 |
RPGR
|
Health Risk |
Likely pathogenic |
— |
| RS1057519237 |
TTN
|
Health Risk |
Likely pathogenic |
— |
| RS1057519240 |
KIF1A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 30, Neuropathy |
| RS1057519242 |
NPC1
|
Health Risk |
Likely pathogenic |
— |
| RS1057519244 |
OPA1
|
Health Risk |
Likely pathogenic |
Autosomal dominant optic atrophy classic form, Autosomal dominant optic atrophy classic form |
| RS1057519246 |
SGCE
|
Health Risk |
Pathogenic/Likely pathogenic |
Myoclonic dystonia 11, Myoclonic dystonia 11 |
| RS1057519247 |
KCNC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1057519248 |
GRIN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Landau-Kleffner syndrome, Landau-Kleffner syndrome |
| RS1057519249 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Breast-ovarian cancer, familial |
| RS1057519251 |
DSP
|
Health Risk |
Pathogenic |
Arrhythmogenic cardiomyopathy with wooly hair and keratoderma, Arrhythmogenic right ventricular dysplasia 8 |
| RS1057519256 |
POLE
|
Health Risk |
Likely pathogenic |
Colorectal cancer, susceptibility to |
| RS1057519261 |
VHL
|
Health Risk |
Conflicting classifications of pathogenicity |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS1057519262 |
CAD
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 50 |
| RS1057519263 |
EPHB4
|
Health Risk |
Pathogenic |
Lymphatic malformation 7, Lymphatic malformation 7 |
| RS1057519264 |
EPHB4
|
Health Risk |
Pathogenic |
Lymphatic malformation 7, Lymphatic malformation 7 |
| RS1057519265 |
ZNF148
|
Health Risk |
Pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS1057519266 |
ZNF148
|
Health Risk |
Pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS1057519267 |
ZNF148
|
Health Risk |
Pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS1057519268 |
ZNF148
|
Health Risk |
Likely pathogenic |
Global developmental delay, absent or hypoplastic corpus callosum |
| RS1057519269 |
AP3B2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1057519270 |
AP3B2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1057519271 |
AP3B2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1057519272 |
AP3B2
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 48 |
| RS1057519273 |
PLPBP
|
Health Risk |
Pathogenic |
Epilepsy, early-onset |
| RS1057519274 |
HCN4
|
Health Risk |
Pathogenic |
Sick sinus syndrome 2, autosomal dominant |
| RS1057519275 |
HCN4
|
Health Risk |
Pathogenic/Likely pathogenic |
Sick sinus syndrome 2, autosomal dominant |
| RS1057519276 |
HCN4
|
Health Risk |
Pathogenic |
Sick sinus syndrome 2, autosomal dominant |
| RS1057519277 |
ACP4
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta, type 1J |
| RS1057519278 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS1057519279 |
KMT2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1057519280 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS1057519281 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1057519282 |
KMT2B
|
Health Risk |
Pathogenic |
Dystonia 28, childhood-onset |
| RS1057519283 |
KMT2B
|
Health Risk |
Pathogenic/Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1057519284 |
KMT2B
|
Health Risk |
Likely pathogenic |
Dystonia 28, childhood-onset |
| RS1057519285 |
KMT2B
|
Health Risk |
Conflicting classifications of pathogenicity |
Dystonia 28, childhood-onset |
| RS1057519286 |
MECR
|
Health Risk |
Pathogenic |
Dystonia, childhood-onset |
| RS1057519287 |
MECR
|
Health Risk |
Pathogenic |
Dystonia, childhood-onset |
| RS1057519288 |
GREM2
|
Health Risk |
Pathogenic |
Tooth agenesis, selective |
| RS1057519289 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS1057519290 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 78 |
| RS1057519291 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Autosomal recessive spastic paraplegia type 78 |
| RS1057519292 |
ATP13A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS1057519293 |
ATP13A2
|
Health Risk |
Pathogenic |
Autosomal recessive spastic paraplegia type 78, Kufor-Rakeb syndrome |
| RS1057519294 |
SLC25A46
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 1E |
| RS1057519295 |
SLC25A46
|
Health Risk |
Pathogenic |
Neuropathy, hereditary motor and sensory |
| RS1057519296 |
SLC25A46
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, type 1E |
| RS1057519297 |
LARP7
|
Health Risk |
Pathogenic |
Microcephalic primordial dwarfism, Alazami type |
| RS1057519299 |
RMND1
|
Health Risk |
Pathogenic |
Combined oxidative phosphorylation defect type 11, Combined oxidative phosphorylation defect type 11 |
| RS1057519300 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS1057519301 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |
| RS1057519302 |
KIDINS220
|
Health Risk |
Pathogenic |
Spastic paraplegia, intellectual disability |